Psilocybin-assisted therapy has been found to enhance insight, personal meaning and facilitate emotional breakthroughs (Roseman et al, 2019). As part of the therapeutic process, this approach has been suggested to facilitate a shift in patient psychology from experiential avoidance to acceptance and approach (Wolff et al, 2020).
MDMA’s psychological effects are described as empathogenic, as MDMA enhances empathy, and entactogenic since it heightens the intensity of physical and emotional sensations such as touch and safety (Mithoefer, 2016). These psychoactive properties of MDMA make it attractive as a therapeutic agent (Thal & Lommen, 2018).
5-MeO-DMT is an underresearched psychedelic with great potential. The altered state it produces exerts a profound and short-acting effect on consciousness and has led to improvements in wellbeing in naturalistic settings (Uthaug, ). PRISM seeks to pioneer research into this promising and fascinating compound alongside Usona Institute.
Psilocybin-assisted therapy has been found to enhance insight, personal meaning and facilitate emotional breakthroughs (Roseman et al, 2019). As part of the therapeutic process, this approach has been suggested to facilitate a shift in patient psychology from experiential avoidance to acceptance and approach (Wolff et al, 2020).
5-MeO-DMT is an underresearched psychedelic with great potential. The altered state it produces exerts a profound and short-acting effect on consciousness and has led to improvements in wellbeing in naturalistic settings (Uthaug, ). PRISM seeks to pioneer research into this promising and fascinating compound alongside Usona Institute.
5-MeO-DMT is an underresearched psychedelic with great potential. The altered state it produces exerts a profound and short-acting effect on consciousness and has led to improvements in wellbeing in naturalistic settings (Uthaug, ). PRISM seeks to pioneer research into this promising and fascinating compound alongside Usona Institute.